4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Mochida Pharmaceutical Co., Ltd. (4534) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Tokyo, Japan with about 1,479 employees. Its market capitalization is roughly JPY 114 billion. In the fiscal year ended 2026-03-31, 4534 reported JPY 117.0B in revenue and JPY 7.9B in net income.
Mochida Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and healthcare products in Japan.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | JPY 117.0B | JPY 105.2B | JPY 102.9B | JPY 103.3B | — |
| Gross Profit | JPY 56.3B | JPY 53.8B | JPY 52.1B | JPY 55.1B | — |
| Operating Income (EBIT) | JPY 10.1B | JPY 8.1B | JPY 5.8B | JPY 8.5B | — |
| Net Income | JPY 7.9B | JPY 5.7B | JPY 4.5B | JPY 6.6B | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (JPY 2.8B) | (JPY 2.8B) | (JPY 2.9B) | (JPY 3.4B) | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | JPY 182.7B | JPY 160.1B | JPY 158.8B | JPY 158.8B | — |
| Total Liabilities | JPY 42.4B | JPY 29.4B | JPY 30.8B | JPY 32.1B | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4534 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms